Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.
2.

The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness.

Delaney JW, Pinto R, Long J, Lamontagne F, Adhikari NK, Kumar A, Marshall JC, Cook DJ, Jouvet P, Ferguson ND, Griesdale D, Burry LD, Burns KE, Hutchison J, Mehta S, Menon K, Fowler RA; Canadian Critical Care Trials Group H1N1 Collaborative.

Crit Care. 2016 Mar 30;20:75. doi: 10.1186/s13054-016-1230-8.

3.

Corticosteroids for severe influenza pneumonia: A critical appraisal.

Nedel WL, Nora DG, Salluh JI, Lisboa T, Póvoa P.

World J Crit Care Med. 2016 Feb 4;5(1):89-95. doi: 10.5492/wjccm.v5.i1.89. eCollection 2016 Feb 4. Review.

4.

Pandemic Influenza A (H1N1) Virus Infection Increases Apoptosis and HIV-1 Replication in HIV-1 Infected Jurkat Cells.

Wang X, Tan J, Biswas S, Zhao J, Devadas K, Ye Z, Hewlett I.

Viruses. 2016 Feb 2;8(2). pii: E33. doi: 10.3390/v8020033.

5.

Autophagy is involved in regulating the immune response of dendritic cells to influenza A (H1N1) pdm09 infection.

Zang F, Chen Y, Lin Z, Cai Z, Yu L, Xu F, Wang J, Zhu W, Lu H.

Immunology. 2016 May;148(1):56-69. doi: 10.1111/imm.12587. Epub 2016 Feb 25.

PMID:
26800655
6.
7.

Postpandemic H1N1 influenza infection in ICU: Are we any wiser now?

Gurjar M.

Indian J Crit Care Med. 2015 Nov;19(11):633-5. doi: 10.4103/0972-5229.169323. No abstract available.

8.

Influenza Vaccine is Protective Against Laboratory-confirmed Influenza in Obese Children.

Smit MA, Wang HL, Kim E, Barragan N, Aldrovandi GM, El Amin AN, Mascola L, Pannaraj PS.

Pediatr Infect Dis J. 2016 Apr;35(4):440-5. doi: 10.1097/INF.0000000000001029.

PMID:
26658380
9.

Infectious Progeny of 2009 A (H1N1) Influenza Virus Replicated in and Released from Human Neutrophils.

Zhang Z, Huang T, Yu F, Liu X, Zhao C, Chen X, Kelvin DJ, Gu J.

Sci Rep. 2015 Dec 7;5:17809. doi: 10.1038/srep17809.

10.

Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury.

Sugiyama MG, Gamage A, Zyla R, Armstrong SM, Advani S, Advani A, Wang C, Lee WL.

J Virol. 2015 Dec 4;90(4):1812-23. doi: 10.1128/JVI.02599-15.

11.

Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.

Mohn KG, Cox RJ, Tunheim G, Berdal JE, Hauge AG, Jul-Larsen Å; Norwegian Pandemic Group, Peters B, Oftung F, Jonassen CM, Mjaaland S.

PLoS One. 2015 Nov 25;10(11):e0143281. doi: 10.1371/journal.pone.0143281. eCollection 2015.

12.

Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico.

Mata-Marín LA, Mata-Marín JA, Vásquez-Mota VC, Arroyo-Anduiza CI, Gaytán-Martínez JE, Manjarrez-Téllez B, Ochoa-Carrera LA, Sandoval-Ramírez JL.

BMC Res Notes. 2015 Sep 11;8:432. doi: 10.1186/s13104-015-1349-8.

13.

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies.

Garcia-Sicilia J, Arístegui J, Omeñaca F, Carmona A, Tejedor JC, Merino JM, García-Corbeira P, Walravens K, Bambure V, Moris P, Caplanusi A, Gillard P, Dieussaert I.

Hum Vaccin Immunother. 2015;11(10):2359-69. doi: 10.1080/21645515.2015.1063754.

14.

A retrospective evaluation of critically ill patients infected with H1N1 influenza A virus in Bursa, Turkey, during the 2009-2010 pandemic.

Nermin KG, Remzi I, Zeynep A, Ilker C, Meltem OT, Guven O, Ferda K, Halis A.

Afr Health Sci. 2015 Jun;15(2):352-9. doi: 10.4314/ahs.v15i2.7.

15.

Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.

Nosaka N, Yashiro M, Yamada M, Fujii Y, Tsukahara H, Liu K, Nishibori M, Matsukawa A, Morishima T.

Crit Care. 2015 Jun 11;19:249. doi: 10.1186/s13054-015-0983-9.

16.

The Tie2-agonist Vasculotide rescues mice from influenza virus infection.

Sugiyama MG, Armstrong SM, Wang C, Hwang D, Leong-Poi H, Advani A, Advani S, Zhang H, Szaszi K, Tabuchi A, Kuebler WM, Van Slyke P, Dumont DJ, Lee WL.

Sci Rep. 2015 Jun 5;5:11030. doi: 10.1038/srep11030.

17.

TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia.

Rendón-Ramirez EJ, Ortiz-Stern A, Martinez-Mejia C, Salinas-Carmona MC, Rendon A, Mata-Tijerina VL, Rosas-Taraco AG.

Viral Immunol. 2015 Jun;28(5):248-54. doi: 10.1089/vim.2014.0123. Epub 2015 Apr 29.

18.

Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis.

Zhang Y, Sun W, Svendsen ER, Tang S, MacIntyre RC, Yang P, Zhang D, Wang Q.

Crit Care. 2015 Feb 20;19:46. doi: 10.1186/s13054-015-0764-5.

19.

Estimates of the demand for mechanical ventilation in the United States during an influenza pandemic.

Meltzer MI, Patel A, Ajao A, Nystrom SV, Koonin LM.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S52-7. doi: 10.1093/cid/civ089.

20.

Risk factors for death from Influenza A(H1N1)pdm09, State of São Paulo, Brazil, 2009.

Ribeiro AF, Pellini AC, Kitagawa BY, Marques D, Madalosso G, de Cassia Nogueira Figueira G, Fred J, Albernaz RK, Carvalhanas TR, Zanetta DM.

PLoS One. 2015 Mar 16;10(3):e0118772. doi: 10.1371/journal.pone.0118772. eCollection 2015.

Items per page

Supplemental Content

Write to the Help Desk